Novavax (NVAX) News Today $7.41 -0.04 (-0.54%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$7.43 +0.02 (+0.27%) As of 06/9/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NVAX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.16 Million Position in Novavax, Inc. (NASDAQ:NVAX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 19.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 268,684 shJune 7 at 3:44 AM | marketbeat.comNovavax Inc.June 5, 2025 | barrons.comNovavax, Inc. (NASDAQ:NVAX) Shares Sold by Nuveen Asset Management LLCNuveen Asset Management LLC decreased its holdings in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 11.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 376,968 shares of the biopharmaceutical company's stock afJune 3, 2025 | marketbeat.comNovavax (NASDAQ:NVAX) Trading Down 5.4% - Time to Sell?Novavax (NASDAQ:NVAX) Stock Price Down 5.4% - Time to Sell?May 30, 2025 | marketbeat.comNovavax (NVAX) Sees Surge in Bullish Option Activity | NVAX Stock NewsMay 30, 2025 | gurufocus.comNovavax to Participate in Upcoming Investor ConferencesMay 29, 2025 | prnewswire.comDeutsche Bank AG Increases Stock Holdings in Novavax, Inc. (NASDAQ:NVAX)Deutsche Bank AG lifted its position in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 47.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 123,581 shares of the biopharmaceutical coMay 28, 2025 | marketbeat.comTwo Sigma Advisers LP Sells 1,219,700 Shares of Novavax, Inc. (NASDAQ:NVAX)Two Sigma Advisers LP cut its position in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 61.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 779,700 shares of the biopharmaceutical comMay 27, 2025 | marketbeat.comMillennium Management LLC Reduces Stake in Novavax, Inc. (NASDAQ:NVAX)Millennium Management LLC lowered its stake in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 48.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,001,433 shares of the biopharmaceutical company's stMay 27, 2025 | marketbeat.comNovavax Target of Unusually Large Options Trading (NASDAQ:NVAX)Novavax, Inc. (NASDAQ:NVAX - Get Free Report) was the target of some unusual options trading on Friday. Stock traders purchased 35,552 call options on the company. This is an increase of approximately 124% compared to the typical daily volume of 15,904 call options.May 25, 2025 | marketbeat.comTwinbeech Capital LP Takes Position in Novavax, Inc. (NASDAQ:NVAX)Twinbeech Capital LP acquired a new stake in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 69,034 shares of the biopharmaceutical company's stock, valued atMay 25, 2025 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by AnalystsShares of Novavax, Inc. (NASDAQ:NVAX - Get Free Report) have received an average recommendation of "Hold" from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and foMay 25, 2025 | marketbeat.comAnalysts Think These Stocks Could More Than Double in Value (NVAX)Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.May 23, 2025 | marketbeat.comBTIG Maintains a Buy rating on Novavax (NVAX)May 22, 2025 | insidermonkey.comBofA Reiterates Hold Rating on Novavax (NVAX) StockMay 21, 2025 | msn.comNovavax: Nuvaxovid FDA Approval Unlocks Several Bullish StimuliMay 21, 2025 | seekingalpha.comJPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive NewsMay 21, 2025 | finance.yahoo.comFDA Sets New Guidelines For Approving COVID-19 Booster Shots In Healthy Individuals: Moderna, Novavax Stocks RiseMay 21, 2025 | msn.comHealthy Returns: Novavax scores narrower Covid vaccine approval after delayMay 20, 2025 | cnbc.comTang Capital Management LLC Sells 400,000 Shares of Novavax, Inc. (NASDAQ:NVAX)Tang Capital Management LLC cut its holdings in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 40.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 600,000 shares of the biopharmaceutical company's stock afteMay 20, 2025 | marketbeat.comJPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive NewsMay 19, 2025 | insidermonkey.comNovavax’s Nuvaxovid Approval and Market Dynamics Justify Hold Rating Amid Unlocked Pipeline PotentialMay 19, 2025 | tipranks.comNovavax Shares Jump 17% FDA Grants Full Approval to COVID VaccineMay 19, 2025 | gurufocus.comTop Stock Movers Now: Tesla, AutoZone, Novavax, and MoreMay 19, 2025 | investopedia.comNovavax Stock (NVAX) Shoots 15% Higher as Covid Vaccine Jab Gets FDA Green LightMay 19, 2025 | tipranks.comStock Movers Alibaba ADRs, Novavax, RedditMay 19, 2025 | bloomberg.comNovavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.May 19, 2025 | barrons.comNovavax shares surge 26% after FDA grants conditional approval for Covid vaccineMay 19, 2025 | proactiveinvestors.comNovavax jumps as FDA clears COVID-19 vaccineMay 19, 2025 | seekingalpha.comNovavax’s COVID-19 Vaccine Gains FDA ApprovalMay 19, 2025 | tipranks.comWhy Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving PremarketMay 19, 2025 | benzinga.comSanofi Invests $55.32 Million in Novavax, Inc. (NASDAQ:NVAX)Sanofi purchased a new position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 6,880,481 shares of the biopharmaceutical company's stock, valued at approximately $55,319,000. NovavaxMay 19, 2025 | marketbeat.comU.S. FDA Approves BLA for Novavax's COVID-19 VaccineMay 19, 2025 | prnewswire.comNovavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety ScrutinyMay 19, 2025 | benzinga.comNorthern Trust Corp Has $11.67 Million Stock Holdings in Novavax, Inc. (NASDAQ:NVAX)Northern Trust Corp boosted its position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 6.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,451,715 shares of the biopharmaceutical company's stock after buying aMay 19, 2025 | marketbeat.comNovavax secures FDA approval for Covid vaccine, but with unexpected limitationsMay 19, 2025 | bizjournals.comFDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage RestrictionsMay 18, 2025 | insidermonkey.comFDA approves Novavax's Covid-19 vaccine with limitationsMay 18, 2025 | msn.comNovavax COVID-19 vaccine approved by FDA with restrictions, AP News saysMay 18, 2025 | msn.comFDA approves Novavax COVID-19 vaccine with restrictionsMay 18, 2025 | msn.comFDA Approves Novavax's (NVAX) COVID-19 Vaccine for Specific Age and Risk Groups | NVAX Stock NewsMay 18, 2025 | gurufocus.comFDA Grants Conditional Approval for Novavax (NVAX) COVID-19 Vaccine | NVAX Stock NewsMay 18, 2025 | gurufocus.comFDA approves Novavax COVID-19 shot but with unusual restrictionsMay 18, 2025 | fortune.comNovavax COVID-19 vaccine approved by the FDAMay 18, 2025 | seekingalpha.comAfter delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high riskMay 18, 2025 | msn.comFDA approves Novavax COVID-19 shot but with unusual restrictionsMay 17, 2025 | financialpost.comFDA approves Novavax COVID-19 shot but with unusual restrictionsMay 17, 2025 | financialpost.comFDA approves Novavax COVID vaccine with new conditionsMay 17, 2025 | reuters.comFDA approves Novavax COVID-19 shot but with unusual restrictionsThe Food and Drug Administration has approved Novavax's COVID-19 vaccine but with unusual restrictionsMay 17, 2025 | marketbeat.comNovavax (NasdaqGS:NVAX) Reports Q1 2025 Financial TurnaroundMay 17, 2025 | finance.yahoo.com Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address NVAX Media Mentions By Week NVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼1.180.69▲Average Medical News Sentiment NVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼311▲NVAX Articles Average Week Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BioCryst Pharmaceuticals News Ligand Pharmaceuticals News Amicus Therapeutics News Celldex Therapeutics News Innoviva News MannKind News Dynavax Technologies News OPKO Health News Geron News Regulus Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWall Street Legend: Crash coming in March—details hereBad News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history give...Chaikin Analytics | SponsoredTrump’s treachery A few months ago, I released a list of six companies I believed were going to appreciate under Trump’s second ...Porter & Company | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
